ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2084

Dendritic Cell-Specific Transmembrane Protein (DC-STAMP) Modulates Bone Resorption in Inflammatory Arthritis and Fracture Repair

Yahui Grace Chiu1, Tzong-Ren Sheu2, Jinbo Li3, Dongge Li4, Michael Thullen2, Brendan Boyce5, Christopher T. Ritchlin6 and Javier Rangel-Moreno7, 1Allergy, Immunology, and Rheumatology, University of Rochester, Rochester, NY, 2Center for Musculoskeletal Research, University of Rochester, Rochester, NY, 3Pathology, University of Rochester, Rochester, NY, 4Allergy, Immunology and Rheumatology, University of Rochester, Rochester, NY, 5University of Rochester, Rochester, NY, 6Allergy, Immunology and Rheumatololgy Division, University of Rochester Medical Center, Rochester, NY, 7Allergy, Immunology & Rheumatology, University of Rochester, Rochester, NY

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Arthritis, bone biology, fractures, osteoblasts and osteoclasts

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 9, 2015

Title: Biology and Pathology of Bone and Joint: Bone Remodeling

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose:

Osteoclasts (OC) direct pathologic bone resorption in osteoporosis and inflammatory arthritis. We previously demonstrated that DC-STAMP (Dendritic Cell-Specific Transmembrane protein), a 7-pass transmembrane protein, is not only essential for cell fusion during osteoclastogenesis but mice that lack this molecule also show impaired osteoblast (OB) differentiation. OC precursors arise from CD14+DC-STAMP+ cells in humans and the frequency of CD11b+DC-STAMP+ cells correlates with the extent of bone erosion in the TNF-Tg arthritis model. A rapid recruitment of DC-STAMP+ mononuclear cells to bone fracture sites and delayed bone healing in DC-STAMP knock-out (KO) mice suggested that DC-STAMP may also modulate fracture repair.

Methods:

(1) To investigate the interplay between DC-STAMP+ cells and OB, we examined the recruitment of DC-STAMP+ cells to the vicinity of OB using a mouse strain (collagen-I cre ROSA-rtta TRE-LacZ) whose OB lineage cells can be traced by the blue LacZ expression. OB differentiation was evaluated with the CFU-ALP and bone nodule formation assays. To examine the role of DC-STAMP+ cells in arthritis progression, we (2) introduced one copy of DC-STAMP knockout locus into the TNF+ mouse line and examined the effect of DC-STAMP KO on OB & OC differentiation and arthritis development; and (3) re-constituted lethally irradiated TNF-Tg mice with bone marrows (BM) from WT or DC-STAMP KO donors and compared arthritis progression between the two groups.

Results:

(1) Histology analysis: TRAP+DC-STAMP+ cells were recruited to the vicinity of LacZ+ OB at the bone fracture sites, whereas OB/OC co-localization was never detected on intact bones without fractures. (2) Genetic analysis: introduction of one DC-STAMP KO locus into the TNF+ background resulted in three phenotypes: (a) bone erosion was less severe; Bone Volume/Total volume (BV/TV: 18.2±5.7 & 12.0±3.1 in TNF+DC-STAMP+/- & TNF+DC-STAMP+/+) mice; (b) 6/15 mice showed asymmetric arthritis, suggesting an alleviated arthritis symptom; (c) OB differentiation was impaired (CFU-f units/well: 112±8 & 225±10 for TNF+DC-STAMP+/- & TNF+DC-STAMP+/+). (3) Bone marrow re-constitution: the expression level of DC-STAMP in the adoptively-transferred cells was up-regulated in the TNF+ background (the mean fluorescence intensity (MFI) in TNF+ and TNF- recipients were 1,205±82 & 723±98, respectively). TNF+ mice that received DC-STAMP+/+ donor cells developed severe arthritis approximately one week earlier than those receiving the DC-STAMP-/- donor cells (deformation scores: 8.0±2.5 & 5.0±3.2 for DC-STAMP+/+ & DC-STAMP-/- donors, respectively, at week-4 post-adoptive transfer).

Conclusion:

Aggregation of DC-STAMP+ cells around OB at fracture sites suggests that DC-STAMP is involved in OB:OC interactions. Arrested OB differentiation in DC-STAMP+/-TNF-Tg mice confirms our initial observations that DC-STAMP is required for adequate OB function. Moreover, DC-STAMP expression level increased in the presence of elevated in vivo TNFa concentration. Collectively, our data indicate that arthritis pathogenesis and bone repair can be modulated by the gene copy number and expression level of DC-STAMP.


Disclosure: Y. G. Chiu, None; T. R. Sheu, None; J. Li, None; D. Li, None; M. Thullen, None; B. Boyce, None; C. T. Ritchlin, AbbVie, 5,Amgen, 5,Novartis Pharmaceutical Corporation, 5,Eli Lilly and Company, 5,Boehringer Ingelheim, 5,Sanofi-Aventis Pharmaceutical, 5,Amgen, 2,AbbVie, 2,UCB Pharma, 2; J. Rangel-Moreno, None.

To cite this abstract in AMA style:

Chiu YG, Sheu TR, Li J, Li D, Thullen M, Boyce B, Ritchlin CT, Rangel-Moreno J. Dendritic Cell-Specific Transmembrane Protein (DC-STAMP) Modulates Bone Resorption in Inflammatory Arthritis and Fracture Repair [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/dendritic-cell-specific-transmembrane-protein-dc-stamp-modulates-bone-resorption-in-inflammatory-arthritis-and-fracture-repair/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/dendritic-cell-specific-transmembrane-protein-dc-stamp-modulates-bone-resorption-in-inflammatory-arthritis-and-fracture-repair/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology